Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DC preparations for therapy.

A M Rice1, K L Jones, D N J Hart

  • 1Cancer Biotherapy Laboratory, Mater Medical Research Institute, South Brisbane, QD, Australia.

Cytotherapy
|June 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes distress and depression are independently associated with gastrointestinal symptoms in type 2 diabetes in Bangladesh.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

First Direct Measurement Constraining the ^{34}Ar(α,p)^{37}K Reaction Cross Section for Mixed Hydrogen and Helium Burning in Accreting Neutron Stars.

Physical review letters·2023
Same author

The impact of micronutrient supplementation in alcohol-exposed pregnancies on reaction time responses of preschoolers in Ukraine.

Alcohol (Fayetteville, N.Y.)·2021
Same author

Digesting the pathogenesis of diabetic gastroparesis.

Journal of diabetes and its complications·2021
Same author

New ^{13}C(α,n)^{16}O Cross Section with Implications for Neutrino Mixing and Geoneutrino Measurements.

Physical review letters·2020
Same author

Key ^{19}Ne States Identified Affecting γ-Ray Emission from ^{18}F in Novae.

Physical review letters·2019
Same journal

Dialysis bioreactor enables high-density, serum-free expansion of dental pulp-derived mesenchymal stromal cells with enhanced secretome.

Cytotherapy·2026
Same journal

Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?

Cytotherapy·2026
Same journal

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026
Same journal

Manufacturing strategies for prolonged CAR-T cell persistence.

Cytotherapy·2026
Same journal

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026
Same journal

Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.

Cytotherapy·2026
See all related articles

This review compares dendritic cell (DC) preparations for cancer immunotherapy. It examines various DC-based treatments being investigated in labs and clinics for their potential to fight cancer.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Cancer immunotherapy aims to harness the immune system to eliminate tumors.
  • Dendritic cells (DCs) are potent antigen-presenting cells crucial for initiating anti-tumor immune responses.
  • Developing effective DC-based cancer vaccines requires optimized DC preparation methods.

Purpose of the Study:

  • To review and compare current dendritic cell (DC) preparations for cancer immunotherapy.
  • To evaluate the status of laboratory and clinical investigations of these DC preparations.
  • To provide insights into the potential of DC-based therapies in oncology.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Comparative analysis of different DC preparation techniques.

Related Experiment Videos

  • Assessment of DC characteristics and functional assays.

    • Main Results:

    • Multiple DC preparation strategies are under investigation.
    • Variations exist in DC sourcing, maturation, and antigen loading methods.
    • Early-stage clinical data suggest potential efficacy but highlight challenges.

    Conclusions:

    • Dendritic cell preparations represent a promising avenue for cancer immunotherapy.
    • Further research and standardization of DC preparation protocols are necessary.
    • Optimized DC-based strategies hold potential for improving cancer treatment outcomes.